In 2008 in Ghana, 35% of anti-malarias were found to be substandard or counterfeit. To address this, companies that have produced fake products are being named and shamed. Through collaborative work, in 2011, this figure had reduced to below 5%. But this is just the start of what needs to be done.
Contributor is:
Stephen Opuni, Chief Executive, Food and Drugs Authority, Accra
Other podcasts in this series
Counterfeit and fake medicines with Duncan Learmouth, Senior Vice President, Developing Countries and Market Access, GlaxoSmithKline plc, Brentford
